• A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer

    Recruiting

    1 1 1
    France Italy Poland Spain
  • Study of budesonide suppositories to treat acute radiation proctitis in men with prostate cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Austria Germany
  • A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

    Recruiting

    4 1 1
    The Netherlands Sweden
  • A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Hungary Italy +2
  • A study to evaluate the long-term safety of apremilast in children with oral ulcers from Behçet’s disease or juvenile psoriatic arthritis

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Greece Italy Spain
  • A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

    Recruiting

    2 1 1
    Investigated diseases:
    Belgium France Italy Spain
  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Germany Hungary Italy Slovakia +1
  • Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +7
  • A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

    Recruiting

    2 1
    Investigated diseases:
    Belgium Czechia Denmark France Germany Greece +3
  • A study of SKB410, enfortumab vedotin, and pembrolizumab combination for patients with locally advanced or metastatic urothelial cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Spain

powered by